BofA raised the firm’s price target on IBM (IBM) to $290 from $270 and keeps a Buy rating on the shares. The firm continues to view IBM as a defensive investment with improving revenue growth and cites expectations for the strength and duration of z17 and associated benefit to Transaction processing for its increased target on the shares, the analyst tells investors in a note issued following the BofA 2025 Global Technology Conference.
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade IBMPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- Q-Day Countdown: How Quantum Computing Could Break Encryption and Reshape Tech Stocks
- IBM and Inclusive Brains Work Together to Make Mind-Controlled Devices More Common
- AI Daily: Apple’s AI launch in China delayed amid U.S.-China tensions
- CoreWeave Stock (CRWV) Rises after Achieving a Major Milestone
- CoreWeave says MLPerf results ‘reinforce our leadership’